header
HOME HEPATITIS B
VIRUS (HBV)
HBV ANTIVIRAL
RESISTANCE
CLINICAL MANAGEMENT
OF HBV RESISTANCE
SeqHepB HBV RESISTANCE TESTING LATEST
NEWS
CLINICAL REFERENCES
& LINKS

OUR PEOPLE

Greg Johnson – Chairman

Greg has over 25 years' experience in the healthcare industry and has 15 years' experience in chief executive level roles in hospitals and health services. He is a Director/Board Member of Melbourne Health (including The Royal Melbourne Hospital) and Chairs the Finance and Audit Committees.

He has been a Surveyor for the Australian Council on Healthcare Standards for over 14 years, is an Associate Fellow of the College of Health Services Executives and a Member of the Australian Institute of Company Directors. He has participated in a range of industry and government advisory committees.

He is Executive Sponsor of the National Diabetes Action Program for Diabetes Australia, and a member of the Executive Committee for the National Diabetes Services Scheme.

He was also appointed an Ambassador for the Victorian Government's "Go For Your Life" initiative, and is active in various health promotion campaigns targeting the dual epidemics of Type 2 diabetes and obesity.

Jon Lamb – Non-Executive Director

Formerly Chief Executive Officer with Beecham New Zealand, Jon joined Beecham's marketing division in brand management and new product development working in South Africa, London, Australia and New Zealand. At age thirty, he was the youngest CEO in the Group and reluctantly left the company after his family decided to settle permanently in New Zealand.

Jon has held Directorships of both public and private companies with a focus in the bio-medical field. He has acted as adviser to both the Thai Government and the then newly elected Mandela Government in South Africa as Advisor to the Strategic Planning Council.

Jon brings a wealth of over thirty years international experience in the pharmaceutical and bio-medical arena ranging from private start up companies to multinational public corporations.

Bernie Romanin – Evivar Medical CEO

Bernie has healthcare experience in Diagnostics, Pharmaceuticals and Medical Devices gained over 30 years in Australia and internationally.

He has extensive commercial expertise in sales and marketing, technology licensing and partnership management.

He has experience in managing start-up and new market business opportunities. During almost a decade in the USA with Chiron and Siemens, he has directed market development activities to identify, validate and commercialise new opportunities in molecular-based and immuno-based diagnostics in the areas of Infectious Diseases (Hepatitis and HIV/AIDS), Oncology, Cardiovascular Disease and Metabolic Disorders.

J.A. (Tony) Wigginton – Non Executive Director

Tony is a qualified accountant and company secretary. He has over 26 years experience in the banking and stockbroking industry, both in Australia and overseas. He has held executive management positions with a number of major international banks in Australia, the United States and Asia. He is currently a director of an ASX listed company.

      Privacy Policy | Disclaimer

All material © Evivar Medical Pty. Ltd. All rights reserved.